Haemonetics EBIT Margin 2010-2025 | HAE

Haemonetics ebit margin from 2010 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Haemonetics EBIT Margin 2010-2025 | HAE

Haemonetics ebit margin from 2010 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$233.7B
Boston Scientific (BSX)$152.8B
Stryker (SYK)$144.4B
EssilorLuxottica (ESLOY)$136.8B
Medtronic (MDT)$119.1B
Lonza Group Ag (LZAGY)$47.4B
Haleon (HLN)$42.9B
ResMed (RMD)$41.6B
GE HealthCare Technologies (GEHC)$32.9B
Agilent Technologies (A)$32.6B
Terumo (TRUMY)$27.5B
Koninklijke Philips (PHG)$25.8B
Insulet (PODD)$21.6B
Zimmer Biomet Holdings (ZBH)$19.7B
Smith & Nephew SNATS (SNN)$15.8B
Baxter (BAX)$12.2B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7.2B
Lantheus Holdings (LNTH)$3.9B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
Prestige Consumer Healthcare (PBH)$3.2B
Perrigo (PRGO)$3.1B
ICU Medical (ICUI)$2.8B
LeMaitre Vascular (LMAT)$2.1B
AtriCure (ATRC)$1.8B
QuidelOrtho (QDEL)$1.6B
Green Thumb Industries (GTBIF)$1.5B
Curaleaf Holdings (CURLF)$1.4B